ag-1296 has been researched along with pd 98059 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
| Clowes, AW; Daum, G; Defawe, O; Kenagy, RD; Millette, E; Rauch, BH | 1 |
| Belmonte, KE; Connell, M; Fujiwara, Y; Gorshkova, I; Long, J; Natarajan, V; Pyne, NJ; Pyne, S; Tigyi, G; Waters, CM | 1 |
| Andresen, BT; Escano, CS; Gutweiler, AA; Keever, LB | 1 |
| Hanai, Y; Harada, A; Kato, H; Kozawa, O; Matsushima-Nishiwaki, R; Ogura, S; Takai, S; Tokuda, H | 1 |
| Cheng, SE; Chi, PL; Hsiao, LD; Hsu, CK; Lee, IT; Yang, CM | 1 |
| Adeyemi, OS; Han, Y; Kabir, MHB; Kato, K | 1 |
8 other study(ies) available for ag-1296 and pd 98059
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |
Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.
Topics: Aorta, Abdominal; Becaplermin; Cell Division; Cell Movement; Cells, Cultured; Chromones; DNA Replication; Enzyme Activation; Fibroblast Growth Factor 2; Flavonoids; Heparin; Humans; Indoles; Maleimides; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-sis; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; Recombinant Proteins; RNA, Small Interfering; Tyrphostins | 2005 |
Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1.
Topics: Animals; Cell Line; Cell Movement; Cells, Cultured; Flavonoids; Guinea Pigs; Humans; Kidney; MAP Kinase Signaling System; PC12 Cells; Platelet-Derived Growth Factor; Rats; Receptor, Platelet-Derived Growth Factor beta; Receptors, Lysosphingolipid; Transfection; Tyrphostins | 2006 |
Angiotensin II activates extracellular signal-regulated kinase independently of receptor tyrosine kinases in renal smooth muscle cells: implications for blood pressure regulation.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Kidney; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor; Protein Tyrosine Phosphatases; Quinazolines; Rats; Rats, Inbred WKY; Receptor Protein-Tyrosine Kinases; Receptors, Platelet-Derived Growth Factor; Tyrphostins; Vasoconstrictor Agents | 2008 |
Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts.
Topics: Animals; Animals, Newborn; Anthracenes; Becaplermin; Cell Line; Dose-Response Relationship, Drug; Drug Synergism; Fibroblast Growth Factor 2; Flavonoids; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinase 3; Models, Biological; Osteoblasts; Phosphorylation; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Receptor, Platelet-Derived Growth Factor beta; Tyrphostins; Vascular Endothelial Growth Factor A | 2008 |
TNF-α induces cytosolic phospholipase A2 expression via Jak2/PDGFR-dependent Elk-1/p300 activation in human lung epithelial cells.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Chromones; Dinoprostone; E1A-Associated p300 Protein; Enzyme Activation; Enzyme Inhibitors; ets-Domain Protein Elk-1; Flavonoids; Humans; Janus Kinase 2; Lung; Mitogen-Activated Protein Kinase 1; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Phospholipases A2; Phosphorylation; Pneumonia; Promoter Regions, Genetic; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha; Tyrphostins | 2014 |
Screening of compound libraries for inhibitors of Toxoplasma growth and invasion.
Topics: Animals; Antiprotozoal Agents; Cell Differentiation; Cell Survival; Flavonoids; Humans; Nitriles; Protein Kinase Inhibitors; Protein Kinases; Pyrimethamine; Signal Transduction; Sulfones; Toxoplasma; Toxoplasmosis; Tyrphostins | 2020 |